Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
07/2004
07/29/2004CA2512184A1 Pyridine derivatives useful for inhibiting sodium/calcium exchange system
07/29/2004CA2510400A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004CA2510382A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
07/29/2004CA2507948A1 Aminoindazole derivates and use thereof as kinase inhibitors
07/28/2004EP1441224A2 Enzyme inhibition immunoassay
07/28/2004EP1440067A1 N-formyl derivatives of paroxetine
07/28/2004EP1440066A1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
07/28/2004EP1440060A1 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
07/28/2004EP1439885A1 Simplified sarcodictyn derivatives as anti-tumor agents
07/28/2004EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
07/28/2004EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/28/2004EP1176958B1 Novel catechols as antimicrobial agents
07/28/2004CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof
07/28/2004CN1516699A Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/28/2004CN1516698A Arylindenopyridines with PDE inhibiting activity
07/28/2004CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents
07/28/2004CN1516691A Phenylpyridine carbonyl piperazine derivative
07/28/2004CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
07/28/2004CN1516587A Quinazoline derivatives capable of promoting release of parathyroid
07/28/2004CN1516585A Process for preparing paroxetine HCI which limits formation of pink colored compounds
07/28/2004CN1516580A Sulfonamides
07/28/2004CN1515569A Indole and 2,3-indoline derivative, their preparation and application
07/28/2004CN1515568A Indole and 2,3-indoline derivative, their preparation and application
07/28/2004CN1515566A Substituted chromene derivative for curing inflammation
07/28/2004CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same
07/28/2004CN1159299C Arylakylpyridzinones
07/28/2004CN1159297C N-([1,2,4]triazoleo azine group) benzene sulfonamide and pyridine sulfamide compound and their use as herbicide
07/28/2004CN1159293C 5-aroylnaphthalene derivatives
07/27/2004US6768010 Organophotoreceptor with an epoxy-modified charge transport compound having an azine group
07/27/2004US6767916 Chalcone coumarins
07/27/2004US6767907 For therapy of psychic and neurologic disorders
07/22/2004WO2004060884A1 [4-(3-aminomethylphenyl) piperidin-1-yl]- [5-(2-fluorophenylethynyl)furan-2-yl]-methanone as an inhibitor of mast cell tryptase
07/22/2004WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004WO2004060874A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004WO2004060870A1 Novel cb 1 receptour inverse agonists
07/22/2004WO2004060865A2 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines
07/22/2004WO2004060371A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004WO2004029045A3 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof
07/22/2004WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same
07/22/2004WO2003087086A3 Substituted indoles
07/22/2004WO2002096886A8 Pyrimidine derivatives
07/22/2004WO2002088090A3 Pyrazole derived kinase inhibitors
07/22/2004US20040143123 zirconium complexes of bis(o-hydroxybenzylamines); further reaction of dicarbonyls such as methyl (2S)-5-chloro-2,3-dihydro-2-hydroxy-1-oxo-1H-indene-2-carboxylate with protected hydrazine and N-(XC(O))-N-methoxycarbonyl-p-(trifluoromethyl)aniline
07/22/2004US20040143122 e.g., 2',7'-Bis(pyridyl-2-sulfonamido)-4',5'-dimethylfluorescein, and 2',7'-Bis(pyridyl-2-methylamino)-4',5'-dimethylfluorescein; Zn-chelating compounds that bind to a specific target sequence, especially on the surface of living cells;
07/22/2004US20040143120 ratio of paroxetine to maleic acid (by mole) is 1:1 or 2:1; crystalline and noncrystalline foms; antidepressant
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142997 Alzheimer's disease
07/22/2004US20040142996 Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation
07/22/2004US20040142981 Sterilization, antiseptics for bacteria infections
07/22/2004US20040142980 Viricides; hepatitis virus infections
07/22/2004US20040142979 Cardiovascular disorders; respiratory system disorders; kidneys; liver diosrders; central nervous system diosrders; osteoarthritis; antiarthritic agents; antitumor agents; multiple sclerosis
07/22/2004US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/22/2004US20040142977 4-Substituted-picolinic acid amide derivatives useful as fungicides
07/22/2004US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease
07/22/2004US20040142975 Antiarthritic agents; canticancer agents; antitumor agents; cardiovascular diosrders; skin diosrders; vision defects; antiinflammatory agents
07/22/2004US20040142972 Sleep disorders; side effect reduction ; antihistamine antagonist
07/22/2004US20040142967 Pain maintenance
07/22/2004US20040142966 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142965 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
07/22/2004US20040142956 Piperidine derivatives
07/22/2004US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders
07/22/2004US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity
07/22/2004US20040142928 particularly against herpes viruses
07/22/2004US20040142924 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
07/22/2004US20040142922 Benzodioxole derivatives
07/22/2004US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases
07/22/2004US20040142850 Benzimidazolidinone derivatives
07/22/2004DE10301110A1 Substituierte Benzoylderivate als Herbizide Substituted benzoyl derivatives as herbicides
07/22/2004DE10300973A1 Neue Carbonsäuren und deren Ester, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New carboxylic acids and esters thereof, pharmaceutical compositions containing them and processes for their preparation
07/22/2004DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs
07/22/2004CA2512346A1 Imino acid derivatives for use as inhibitors of matrix metalloproteinases
07/22/2004CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors
07/22/2004CA2511859A1 Novel cb 1 receptor inverse agonists
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
07/21/2004EP1439175A1 Pyrimidine compound and medicinal composition thereof
07/21/2004EP1439174A1 4-imidazolin-2-one compounds
07/21/2004EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
07/21/2004EP1438306A2 Derivatives of uk-2a
07/21/2004EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity
07/21/2004EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
07/21/2004EP1438295A2 Azole derivatives and pharmaceutical compositions containing them
07/21/2004EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents
07/21/2004EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
07/21/2004EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
07/21/2004CN1514833A Novel tyrosine kinase inhibitors
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1514727A Favorable modulation of health-related quality of life and health-related quality-adjusted time-to progression of disease in patients with prostate cancer
07/21/2004CN1513844A New Carboxglic acid derivative, its preparation and application
07/21/2004CN1158274C Benzopyran-containing compounds and method for their use
07/21/2004CN1158272C Substituted benzodihydropyranyl sulfonylurea, its preparation, use in medicines and medicines containing the same
07/21/2004CN1158267C Thiocyano-triazolyl derivatives and their use as microbicides
07/21/2004CN1158266C Compounds
07/21/2004CN1158258C Alpha 1 beta-adrenergic receptor antagonists
07/21/2004CN1158256C Pyrrolidine derivatives-CCR-3 receptor antagonists
07/20/2004US6765097 Process for the preparation of aryl-pyridinyl compounds